Motolese M - Search Results

1

Blunting of atrial natriuretic factor response to volume expansion by benazepril in hypertensive patients.

Dessì-Fulgheri P, Motolese M, Di Noto G, Delfino D, Giacchetti G, Boria C, Rappelli A. Dessì-Fulgheri P, et al. Among authors: motolese m. J Hypertens Suppl. 1989 Dec;7(6):S300-1. doi: 10.1097/00004872-198900076-00146. J Hypertens Suppl. 1989. PMID: 2561144 Clinical Trial.

2

Effects of benazepril on stress testing blood pressure in essential hypertension.

Cardillo C, Mores N, Motolese M, Folli G. Cardillo C, et al. Among authors: motolese m. Am J Cardiol. 1994 Feb 15;73(5):368-73. doi: 10.1016/0002-9149(94)90010-8. Am J Cardiol. 1994. PMID: 8109551 Clinical Trial.

3

Effect of evening versus morning benazepril on 24-hour blood pressure: a comparative study with continuous intraarterial monitoring.

Palatini P, Mos L, Motolese M, Mormino P, Del Torre M, Varotto L, Pavan E, Pessina AC. Palatini P, et al. Among authors: motolese m. Int J Clin Pharmacol Ther Toxicol. 1993 Jun;31(6):295-300. Int J Clin Pharmacol Ther Toxicol. 1993. PMID: 8335427 Clinical Trial.

4

Short-term metabolic effects of the ACE-inhibitor benazepril in type 2 diabetes mellitus associated with arterial hypertension.

De Feo P, Torlone E, Perriello G, Fanelli C, Epifano L, Di Vincenzo A, Modarelli F, Motolese M, Brunetti P, Bolli GB. De Feo P, et al. Among authors: motolese m. Diabete Metab. 1992 Jul-Aug;18(4):283-8. Diabete Metab. 1992. PMID: 1459316 Clinical Trial.

5

Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group.

Maschio G, Alberti D, Janin G, Locatelli F, Mann JF, Motolese M, Ponticelli C, Ritz E, Zucchelli P. Maschio G, et al. Among authors: motolese m. N Engl J Med. 1996 Apr 11;334(15):939-45. doi: 10.1056/NEJM199604113341502. N Engl J Med. 1996. PMID: 8596594 Free article. Clinical Trial.

6

Fixed combination of benazepril and low-dose amlodipine in the treatment of mild to moderate essential hypertension: evaluation by 24-hour noninvasive ambulatory blood pressure monitoring.

Fogari R, Zoppi A, Lusardi P, Mugellini A, Preti P, Motolese M. Fogari R, et al. Among authors: motolese m. J Cardiovasc Pharmacol. 1997 Aug;30(2):176-81. doi: 10.1097/00005344-199708000-00005. J Cardiovasc Pharmacol. 1997. PMID: 9269944 Clinical Trial.

7

Long-term progression of chronic renal insufficiency in the AIPRI Extension Study. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group.

Locatelli F, Carbarns IR, Maschio G, Mann JF, Ponticelli C, Ritz E, Alberti D, Motolese M, Janin G, Zucchelli P. Locatelli F, et al. Among authors: motolese m. Kidney Int Suppl. 1997 Dec;63:S63-6. Kidney Int Suppl. 1997. PMID: 9407424 Clinical Trial.

8

Long-term effects of benazepril on ambulatory blood pressure, left ventricular mass, diastolic filling and aortic flow in essential hypertension.

Porcellati C, Verdecchia P, Schillaci G, Boldrini F, Motolese M. Porcellati C, et al. Among authors: motolese m. Int J Clin Pharmacol Ther Toxicol. 1991 May;29(5):187-97. Int J Clin Pharmacol Ther Toxicol. 1991. PMID: 1830037

9

Fixed combination of benazepril and very low dose hydrochlorothiazide in the treatment of mild to moderate essential hypertension: evaluation by 24-hour non invasive ambulatory blood pressure monitoring.

Fogari R, Zoppi A, Tettamanti F, Tettamanzi D, Lusardi P, Motolese M. Fogari R, et al. Among authors: motolese m. Int J Clin Pharmacol Ther. 1994 Nov;32(11):606-11. Int J Clin Pharmacol Ther. 1994. PMID: 7874375 Clinical Trial.

10

Evaluation by 24-hour ambulatory blood pressure monitoring of efficacy of benazepril 20 mg plus hydrochlorothiazide 25 mg fixed combination as compared to captopril 50 mg [corrected] plus hydrochlorothiazide 25 mg fixed combination in treating mild to moderate hypertension: a double-blind, within-patient, placebo-controlled study.

Fogari R, Zoppi A, Tettamanti F, Tettamanzi D, Lusardi P, Motolese M. Fogari R, et al. Among authors: motolese m. J Cardiovasc Pharmacol. 1994 Nov;24(5):687-93. doi: 10.1097/00005344-199424050-00001. J Cardiovasc Pharmacol. 1994. PMID: 7869731 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

111 results

Search Page

Filters